Evidence map›Paper›PMID 41105006›Full record

ArticleEpilepsia2025

Paroxysmal slow wave events as a diagnostic biomarker for epilepsy: Lessons from rural Zambia.

Andrew Malunga, Sina Lash, Alaa Abu-Ahmad, Laith Alhadeed, Felix Benninger, Gal Ben-Arie, Nicholas Fearns, Hamza Imtiaz, Stefan Kunst, Anna Minarik and 12 more

Abstract read
In one paragraph

Article in Epilepsia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Andrew MalungaMambwe Health District, Halifax, Eastern Province, Zambia.
Sina LashDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Alaa Abu-AhmadDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Laith AlhadeedDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Felix BenningerDepartment of Neurology, Rabin Medical Center, Petach-Tiva, Israel.ORCID https://orcid.org/0000-0003-3097-4693
Gal Ben-ArieSoroka University Medical Center, Be'er Sheva, Israel.
Nicholas FearnsEpilepsy Center Munich, Department of Neurology, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.
Hamza ImtiazDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Stefan KunstEpilepsy Center Munich, Department of Neurology, University Hospital, Ludwig Maximilian University Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-1237-3344
Anna MinarikDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Mutale MasamuMambwe District Hospital, Mambwe Health District, Mambwe, Eastern Province, Zambia.
George MshangaMambwe Health District, Halifax, Eastern Province, Zambia.
Oliver NealDivision of Neurology, Nova Scotia Health and Dalhousie University, Halifax, Nova Scotia, Canada.
Attila RaczDepartment of Epileptology, University Hospital Bonn, Bonn, Germany.
Theodor RuberDepartment of Epileptology, University Hospital Bonn, Bonn, Germany.ORCID https://orcid.org/0000-0002-6180-7671
Khalid SaadehDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Yonatan SerlinNeurophysiology of Epilepsy Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Merav ShamirKoret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.
Tamara WelteDepartment of Neurology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Benjamin WhatleyDivision of Neurology, Nova Scotia Health and Dalhousie University, Halifax, Nova Scotia, Canada.
Alon FriedmanDepartment of Medical Neuroscience, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.ORCID https://orcid.org/0000-0003-4780-8456
Stanley ZimbaDepartment of Internal Medicine, University Teaching Hospital, Lusaka, Zambia.

Funding

Dennis Chair in Epilepsy Research
6 · The paper itself

Abstract

objectiveEpilepsy affects more than 50 million people globally, with low- and middle-income countries (LMICs) bearing the greatest burden due to limited medical resources and stigma. Electroencephalography (EEG) is a cost-effective diagnostic tool, but its interpretation often requires unavailable expertise in rural areas. There is a pressing need for reliable, quantitative EEG biomarkers to enhance diagnosis, guide imaging, and monitor treatment.

methodsWe investigated paroxysmal slow wave events (PSWEs), transient markers of cortical network slowing, in scalp EEG recordings from epilepsy patients at the Kakumbi Rural Health Center in Zambia (n = 127) and from Bonn Epilepsy Center (n = 132). PSWE characteristics, including occurrence, duration, and spatial distribution, were analyzed. Source localization of PSWEs was performed using standardized low-resolution brain electromagnetic tomography software.

resultsPSWEs were observed in all patients with epilepsy. Time in PSWE showed negative correlation with patient age (r = -.26, p = .003) and disease onset (r = -.25, p = .005), regardless of age. PSWE characteristics, including temporal and spatial distribution, were associated with disease severity and similar to drug-resistant patients from Bonn Epilepsy Center. EEGs reported as "abnormal" had greater time in PSWE compared with "normal" EEGs (p = .024). Focal PSWE source localization suggested the presence of an intracranial lesion on computed tomography (area under the curve = .7). SIGNIFICANCE: This study supports previous research on the potential of PSWEs as a quantitative EEG biomarker in epilepsy. Automated analysis of PSWEs can enhance diagnostic accuracy and assist in screening patients for brain imaging, particularly in resource-constrained settings. This approach offers a practical solution to bridge the diagnostic gap in LMICs that can potentially be used to improve epilepsy management and patient outcomes.

Indexed as

ElectroencephalographyEpilepsyAdolescentAdultBiomarkersChildFemaleHumansMaleMiddle AgedRural PopulationYoung AdultZambiaBiomarkersbiomarkercomputerized tomographyelectroencephalogramepilepsyparoxysmal slow wave eventsrural ZambiasLORETA

Identifiers

PMID41105006
PMCPMC12779313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.